Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy

Abstract

Intravenous immunoglobulin (IVIg) treatment is shown to be effective in a selected group of patients with a chronic inflammatory demyelinating polyneuropathy (CIDP). The proportion ofpatients that improve after IVIg treatment varies between studies. Because 40% of a group of IVIg treated CIDP patients needed intermittent IVIg infusions to maintain their… (More)

Topics

  • Presentations referencing similar topics